Zusammenfassung
Die Viren, die ein einzelsträngiges, durchgängiges RNA-Genom in Negativstrangorientierung haben, fasst man in der Ordnung der Mononegavirales zusammen. Zu ihnen zählen die Familien Rhabdoviridae, Bornaviridae, Paramyxoviridae und Filoviridae.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
15.1.7 Weiterführende Literatur
Albertini, A. A.; Schoehn, G.; Weissenhorn, W.; Ruigrok, R. W. Structural aspects of rabies virus replication. In: Cell. Mol. Life. Sci. 65 (2008) S. 282–294.
Baer, G. M. Rabies — An historical perspective. In: Infect. Agents and Dis. 3 (1994) S. 168–180.
Bronnert, J.; Wilde, H.; Tepsumethanon, V.; Lumlertdacha, B.; Hemachudha, T. Organ transplantations and rabies transmission. In: J. Travel Med. 14 (2007) S. 177–180.
Chelbi-Alix, M. K.; Vidy, A.; El Bougrini, J.; Blondel, D. Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies. In: J. Interferon Cytokine Res. 26 (2006) S. 271–280.
Coil, D. A.; Miller, A. D. Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus In: J. Virol. 78 (2004) S. 10920–10926.
Conzelmann, K. K.; Cox, J. H.; Schneider, L. G.; Thiel, H. J. Molecular cloning and complete nucleotide sequence of the attenuated rabies virus SAD B19. In: Virology 175 (1990) S. 485–499.
Dietzschold, B.; Schnell, M.; Koprowski, H. Pathogenesis of rabies. In: Curr. Top. Microbiol. Immunol. 292 (2005) S. 45–56.
Etessami, R.; Conzelmann, K. K.; Fadai-Ghotbi, B.; Natelson, B.; Tsiang, H.; Ceccaldi, P. E. Spread and pathogenic characteristics of a G-deficient rabies virus recombinant: an in vitro and in vivo study. In: J. Gen. Virol. 81 (2000) S. 214–2153.
Faber, M.; Pulmanausahakul, R.; Nagao, K.; Prosniak, M.; Rice, A. B.; Koprowski, H.; Schnell, M. J.; Dietzschold, B. Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. In: Proc. Natl. Acad. Sci. USA 101 (2004) S. 16328–16332.
Finke, S.; Conzelmann, K. K. Replication strategies of rabies virus. In: Virus Res. 111 (2005) S. 120–131.
Graham, S. C.; Assenberg, R.; Delmas, O.; Verma, A.; Gholami, A.; Talbi, C.; Owens, R. J.; Stuart, D. I.; Grimes, J. M.; Bourhy, H. Rhabdovirus matrix protein structures reveal a novel mode of self-association. In: PLoS. Pathog. 4 (2008) e1000251.
Ito, N.; Takayama M.; Yamada, K.; Sugiyama, M.; Minamoto, N. Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice. In: J. Virol. 75 (2001) S. 9121–9128.
Jackson, A. C. Rabies. In: Can. J. Neurol. Sci. 27 (2000) S. 278–282.
Lafon, J.; Lafage, M.; Martinez-Anrends, A.; Ramirez, R.; Vuillier, F.; Charron, D.; Lotteau, V.; Scott-Algara, D. Evidence of a viral superantigen in humans. In: Nature 358 (1992) S. 507–509.
Lafon, M.; Scott-Algara, D.; Marche, P. N.; Cazenave, P. A.; Jouvin-Marche, E. Neonatal deletion and selective expansion of mouse T cells by exposure to rabiesvirus nucleocapsid superantigen. In: J. Exp. Med. 180 (1994) S. 1207–1215.
Lafon, M. Immune evasion, a critical strategy for rabies virus. In: Dev. Biol. (Basel) 131 (2008) S. 413–419.
Lewis, P.; Fu, Y.; Lentz, T. L. Rabies virus entry into endosomes on IMR-32 human neuroblastoma cells. In: Exp. Neurol. 153 (1998) S. 65–73.
Lewis, P.; Fu, Y.; Lentz, T. L. Rabies virus entry at the neuromuscular junction in nerve-muscle cocultures. In: Muscle Nerve 23 (2000) S. 720–730.
Lichty, B. D.; Power, A. T.; Stojdl, D. F.; Bell, J. C. Vesicular stomatitis virus: re-inventing the bullet. In: Trends Mol. Med. 10 (2004) S: 210–6.
Morimoto, K.; Shoji, Y.; Inoue, S. Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity. In: Virus Res. 11 (2005) S. 61–67.
Nadin-Davis, S. A.; Fehlner-Gardiner, C. Lyssaviruses: current trends. In: Adv. Virus Res. 71 (2008) S. 207–250.
Nel, L. H.; Markotter, W. Lyssaviruses. In: Crit. Rev. Microbiol. 33 (2007) S. 301–324.
Ogino, T.; Banerjee, A. K. Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. In: Mol. Cell. 5 (2007) S. 85–97.
Rose, J. K.; Schubert, M. Rhabdovirus genomes and their products. In: Wagner, R. R. (Hrsg.) The rhabdoviruses. New York (Plenum Press) 1987. S. 129–166.
Rupprecht, C. E.; Dietzschold, B.; Koprowski, H. (Hrsg.) Lyssaviruses. In: Curr. Topics Microbiol. Immunol., Bd. 187. Berlin, Heidelberg, New York (Springer) 1994.
Swanepoel, R. Rabies. In: Coetzer, J. A. W.; Thomson, G. R.; Tustin, R. C. (Hrsg.) Infectious diseases of livestock with special reference to Southern Africa. Oxford University Press. (1995) S. 493–552.
Theerasurakarn, S.; Ubol, S. Apoptosis induction in brain during the fixed strain of rabies virus infection correlates with the onset and severety of illness. In: J. Neurovirol. 4 (1998) S. 407–414.
Thoulouze, M. I.; Lafage, M.; Schachner, M.; Hartmann, U.; Cremer, H.; Lafon, M. The neural cell adhesion molecule is a receptor for rabies virus. In: J. Virol. 72 (1998) S. 7181–7190.
Tuffereau, C.; Schmidt, K.; Langevin, C.; Lafay, F.; Dechant, G.; Koltzenburg, M. The rabies virus glycoprotein receptor p75NTR is not essential for rabies virus infection. In: J. Virol. 81 (2007) S. 13622–13630.
Ubol, S.; Sukwattanapan, C.; Maneerat, Y. Inducible nitric oxide synthase inhibition delays death of rabies virus-infected mice. In: J. Med. Microbiol. 50 (2001) S. 238–242.
Willoughby, R. E. Jr.; Tieves, K. S.; Hoffman, G. M.; Ghanayem, N. S.; Amlie-Lefond, C. M.; Schwabe, M. J.; Chusid, M. J.; Rupprecht, C. E. Survival after treatment of rabies with induction of coma. In: N. Engl. J. Med. 352 (2005) S. 2508–2514.
Weiterführende Literatur
Allmang, U.; Hofer, M.; Herzog, S.; Bechter, K.; Staeheli, P. Low avidity of human serum antibodies for Borna disease virus antigens questions their diagnostic value. In: Mol. Psychiatry 6 (2001) S. 329–333.
Bode, L.; Zimmermann, W.; Ferszt, P.; Steinbach, F.; Ludwig, H. Borna disease virus genome transcribed and expresses in psychiatric patients. In: Nature Medicine 1 (1995) S. 232–237.
Briese, T.; Schneemann, A.; Lewis, A.; Ludwig, H.; Lipkin, W. I. Genomic organization of Borna disease virus. In: Proc. Natl. Acad. Sci. USA 91 (1994) S. 4362–4366.
Chase, G.; Mayer, D.; Hildebrand, A.; Frank, R.; Hayashi, Y.; Tomonaga, K.; Schwemmle, M. Borna disease virus matrix protein is an integral component of the viral ribonucleoprotein complex that does not interfere with polymerase activity. In: J. Virol. 81 (2007) S. 743–749.
Clemente, R.; de la Torre, J. C. Cell entry of Borna Disease Virus follows a clathrin mediated endocytosis pathway that requires Rab5 and microtubules. In: J. Virol. 83 (2009) S. 10406–10416.
Clemente, R.; de la Torre, J. C. Cell-to-cell spread of Borna disease virus proceeds in the absence of the virus primary receptor and furin-mediated processing of the virus surface glycoprotein. In: J. Virol. 81 (2007) S. 5968–5977.
Clemente, R.; de Parseval, A.; Perez, M.; de la Torre, J. C. Borna Disease Virus requires cholesterol in both cellular membrane and viral envelope for efficient cell entry. In: J. Virol. 83 (2009) S. 2655–2662.
Cros, J. F.; Palese, P. Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. In: Virus Res. 95 (2003) S. 3–12.
Cubitt, B.; Ly, C.; Torre, J. C. de la. Identification and characterization of a new intron in Borna disease virus. In: J. Gen. Virol. 82 (2001) S. 641–646.
Dürrwald, R.; Kolodziejek, J.; Herzog, S.; Nowotny, N. Meta-analysis of putative human bornavirus sequences fails to provide evidence implicating Borna disease virus in mental illness. In: Rev. Med. Virol. 17 (2007) S. 181–203.
Hayashi, Y.; Horie, M.; Daito, T.; Honda, T.; Ikuta, K.; Tomonaga, K. Heat shock cognate protein 70 controls Borna disease virus replication via interaction with the viral non-structural protein X. In: Microbes Infect. 11 (2009) S. 394–402.
Honkavuori, K. S.; Shivaprasad, H. L.; Williams, B. L.; Quan, P. L.; Hornig, M.; Street, C.; Palacios, G.; Hutchison, S. K.; Franca, M.; Egholm, M.; Briese, T.; Lipkin, W. I. Novel borna virus in psittacine birds with proventricular dilatation disease. In: Emerg. Infect. Dis. 14 (2008) S. 1883–1886.
Kraus, I.; Bogner, E.; Lilie, H.; Eickmann, M.; Garten, W. Oligomerization and assembly of the matrix protein of Borna disease virus. In: FEBS Lett. 579 (2005) S. 2686–2692.
Ohtaki, N.; Kamitani, W.; Watanabe, Y.; Hayashi, Y.; Yanai, H.; Ikuta, K.; Tomonaga, K. Downregulation of an astrocyte-derived inflammatory protein, S100B, reduces vascular inflammatory responses in brains persistently infected with Borna disease virus. In: J. Virol. 81 (2007) S. 5940–5948.
Peng, G.; Yan, Y.; Zhu, C.; Wang, S.; Yan, X.; Lu, L.; Li, W.; Hu, J.; Wei, W.; Mu, Y.; Chen, Y.; Feng, Y.; Gong, R.; Wu, K.; Zhang, F.; Zhang, X.; Zhu, Y.; Wu, J. Borna disease virus P protein affects neural transmission through interactions with gamma-aminobutyric acid receptor-associated protein. In: J. Virol. 82 (2008) S. 12487–12497.
Perez, M.; Watanabe, M.; Whitt, M. A.; Torre, J. C. de la. N-terminal domain of Borna disease virus G (p56)-protein is sufficient for virus receptor regognition and cell entry. In: J. Virol. 75 (2001) S. 7078–7085.
Poenisch, M.; Burger, N.; Staeheli, P.; Bauer, G.; Schneider, U. Protein X of Borna disease virus inhibits apoptosis and promotes viral persistence in the CNS of newborn-infected rats. In: J. Virol. 83 (2009) S. 4297–4307.
Poenisch, M.; Unterstab, G.; Wolff, T.; Staeheli, P.; Schneider, U. The X protein of Borna disease virus regulates viral polymerase activity through interaction with the P protein. In: J. Gen. Virol. 85 (2004) S. 1895–1898.
Rinder, M.; Ackermann, A.; Kempf, H.; Kaspers, B.; Korbel, R.; Staeheli, P. Broad tissue and cell tropism of avian bornavirus in parrots with proventricular dilatation disease. In: J. Virol. 83 (2009) S. 5401–5407.
Schneider, U.; Martin, A.; Schwemmle, M.; Staeheli, P. Genome trimming by Borna disease viruses: viral replication control or escape from cellular surveillance? In: Cell Mol. Life Sci. 64 (2007) S. 1038–1042.
Staeheli, P.; Stauder, C.; Hausmann, J.; Ehrensperger, F.; Schwemmle, M. Epidemiology of Borna disease virus. In: J. Gen. Virol. 81 (2000) S. 2123–2135.
Torre, J. C. de la. Bornavirus and the brain. In: J. Infect. Dis. 186 (2002) S. 241–247.
Walker, M. P.; Jordan, I.; Briese, T.; Fischer, N.; Lipkin, W. I. Expression and characterization of the Borna disease virus polymerase. In: J. Virol. 74 (2000) S. 4425–4428.
Wolff, T.; Pfleger, R.; Wehner, T.; Reinhardt, J.; Richt, J. A short leucin-rich sequence in the Borna disease virus p10 proteins mediates association with the viral phospho-and nucleoproteins. In: J. Gen. Virol. 81 (2000) S. 939–947.
Weiterführende Literatur
Appel, M. J. G.; Summers, B. A. Pathogenicity of morbilliviruses for terrestial carnivores. In: Veterinary Microbiology 44 (1995) S. 187–191.
Avota, E.; Avots, A.; Niewiesk, S.; Kane, L. P.; Bommhardt, U.; Meulen, V. ter; Schneider-Schaulis, S. Disruption of Akt kinase activation is important for immunosuppression induced by measles virus. In: Nature Medicine 7 (2001) S. 725–731.
Bao, X., Kolli, D., Liu, T., Shan, Y., Garofalo, R. P., Casola, A. Human metapneumovirus small hydrophobic protein inhibits NF-kappaB transcriptional activity. In: J. Virol. 82 (2008) S. 8224–8229.
Barrett, T. Recombinant DNA technology for producing new rinderpest virus vaccines. In: Expert Rev. Vaccines. 4 (2005) S. 113–120.
Bowden, T. A.; Aricescu, A. R.; Gilbert, R. J.; Grimes, J. M.; Jones, E. Y.; Stuart, D. I. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. In: Nat. Struct. Mol. Biol. 15 (2008) S. 567–572.
Briss, P. A.; Fehrs, L. J. et al. Sustained transmission of mumps in a highly vaccinated population: Assessment of primary vaccine failure and waning vaccine-induced immunity. In: J. Infect. Dis. 169 (1994) S. 77–82.
Cuesta, J.; Geng, X.; Asenjo, A.; Villanneva, N. Structural phosphoprotein M 2-1 of the human respiratory syncytialvirus is an RNA binding protein. In: J. Virol. 74 (2000) S. 9858–9867.
Deem, S. L.; Spelman, S. H.; Yates, R. A.; Montali, R. J. Canine distemper in terrestrial carnivores: a review. In: J. Zoo. Wildl. Med. 31 (2000) S. 441–451.
Deffrasnes, C.; Hamelin, M. E.; Boivin, G. Human metapneumovirus. In: Semin. Respir. Crit. Care Med. 28 (2007) S. 213–221.
Dhiman, N.; Jacobson, R. M.; Poland, G. A. Measles virus receptors: SLAM and CD46. In: Rev. Med. Virol. 14 (2004) S. 217–229.
Durbin, A. P.; McAuliffe, J. M.; Collins, P. L.; Murphy, B. R. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates. In: Virology 261 (1999) S. 319–330.
Elliott, J.; Lynch, O. T.; Suessmuth, Y.; Qian, P.; Boyd, C. R.; Burrows, J. F.; Buick, R.; Stevenson, N. J.; Touzelet, O.; Gadina, M.; Power, U. F.; Johnston, J. A. Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. In: J. Virol. 81 (2007) S. 3428–3436.
Erbar, S.; Diederich, S.; Maisner A. Selective receptor expression restricts Nipah virus infection of endothelial cells. In: Virol. J. 5 (2008) 142.
Fontana, J. M.; Bankamp, B.; Rota, P. A. Inhibition of interferon induction and signaling by paramyxoviruses. In: Immunol. Rev. (2008) 225 S. 46–67.
Hoffmann, M. A.; Banerjee, A. K. Analysis of RNA secondary structure in replication of human parainfluenza virus type 3. In: Virology 272 (2000) S. 151–158.
Hoogen, B. G. van den; Jong, J. C. de; Kuiken, T.; Groot, R de.; Fouchier, R. A. M.; Osterhaus A. D. M. E. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. In: Nature Medicine 71 (2001) S. 719–724.
Hooper, P. New fruit bat viruses affecting horses, pigs and humans. In: Brown, C.; Bolin, C. (Hrsg.) Emerging diseases of animals. Washington D.C. (ASM Press) 2000. S. 85–99.
Hviid, A.; Rubin, S.; Mühlemann, K. Mumps. In: Lancet 371 (2008) S. 932–944.
Kahn, J. S. Epidemiology of Human Metapneumovirus. In: Clin. Microbiol. Rev. 19 (2006) S. 546–557.
Lamb, R. A.; Jardetzky, T. S. Structural basis of viral invasion: lessons from paramyxovirus F. In: Curr. Opin. Struct. Biol. 17 (2007) S. 427–436.
Leung, A. K.; Kellner, J. D.; Davies, H. D. Respiratory syncytial virus bronchiolitis. In: J. Natl. Med. Assoc. 97 (2005) S. 1708–1713.
Li, D.; Jans, D. A.; Bardin, P. G.; Meanger, J.; Mills, J.; Ghildyal, R. Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein. In: J. Virol. 82 (2008) S. 8863–8870.
Li, M.; Schmitt, P. T.; Li, Z.; McCrory, T. S.; He, B.; Schmitt, A. P. Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. In: J. Virol. 83 (2009) S. 7261–7272.
Lin, G. Y.; Lamb, R. A. The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. In: J. Virol. 74 (2000) S. 9152–9166.
Ling, Z.; Tran, K. C.; Teng, M. N. Human respiratory syncytial virus nonstructural protein NS2 antagonizes the activation of beta interferon transcription by interacting with RIG-I. In: J. Virol. 83 (2009) S. 3734–3742.
Manchester, M.; Eto, D. E.; Valsamakis, A.; Liton, P. B.; Fernandez-Munoz, R.; Rota, P. A.; Bellini, W. J.; Forthal, D. N.; Oldstone, M. B. A. Clinical isolates of measles virus use CD46 as a cellular receptor. In: J. Virol. 74 (2000) S. 3967–3974.
Moll, M.; Klenk, H.-D.; Herrler, G.; Maisner, A. A single amino acid change in the cytoplasmic domains of measles virus glycoproteins H and F alters targeting, endocytosis, and cell fusion in polarized Madin-Darby canine kidney cells. In: J. Biol. Chem. 276 (2001) S. 17887–17894.
Muscat, M.; Bang, H.; Wohlfahrt, J.; Glismann, S.; Mølbak, K; EUVAC.NET Group. Measles in Europe: an epidemiological assessment. In: Lancet 373 (2009) S. 383–389.
Nokes, J. D.; Cane, P. A. New strategies for control of respiratory syncytial virus infection. In: Curr. Opin. Infect. Dis. 21 (2008) S. 639–643.
Patterson, J. B.; Thomas, D.; Lewick, H.; Billeter, M. A.; Oldstone, M. B. A. V and C proteins of measles virus function as virulence factors in vivo. In: Virology 267 (2000) S. 80–89.
Rima, B. K.; Duprex, W. P. Morbilliviruses and human disease. In: J. Pathol. 208 (2006) S. 199–214.
Rossiter, B. Rinderpest. In: Coetzer, J. A. W.; Thomson, G. R.; Tustin, R. C. (Hrsg.) Infectious diseases of livestock with special reference to Southern Africa. Oxford (Oxford University Press) 1994. S. 735–757.
Russell, C. J.; Luque, L. E. The structural basis of paramyxovirus invasion. In: Trends Microbiol. 14 (2006) S. 243–246.
Schneider-Schaulies, S.; Schneider-Schaulies, J. Measles virusinduced immunosuppression. In: Curr. Top. Microbiol. Immunol. 330 (2009) S. 243–269.
Suzuki, T.; Portner, A.; Scroggs, R. A.; Uchikawa, M.; Koyama, N.; Matsuo, K.; Suzuki, Y.; Takimoto, T. Receptor specifities of human respiroviruses. In: J. Virol. 75 (2001) S. 4604–4613.
Tatsuo, H.; Ono, N.; Yanagi, Y. Morbilliviruses use signalling lymphocyte activation molecules (CD150) as cellular receptors. In: J. Virol. 75 (2001) S. 5842–5850.
Tebbey, P. W.; Hagen, M.; Hancock, G. E. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. In: J. Exp. Med. 188 (1998) S. 1967–1972.
Warris, A.; Groot, R. de. Human metapneumovirus: an important cause of acute respiratory illness. In: Adv. Exp. Med. Biol. 582 (2006) S. 251–264.
Weingartl, H. M.; Berhane, Y.; Czub, M. Animal models of henipavirus infection: A review. In: Vet. J. 181 (2008) S. 211–220.
Wild, T. F. Henipaviruses: a new family of emerging Paramyxoviruses. In: Pathol. Biol. (Paris) 57 (2009) S. 188–196.
Xu, K.; Rajashankar, K. R.; Chan, Y. P.; Himanen, J. P.; Broder, C. C.; Nikolov, D. B. Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. In: Proc. Natl. Acad. Sci. USA 105 (2008) S. 9953–9958.
Yanagi, Y.; Takeda, M.; Ohno, S. Measles virus: cellular receptors, tropism and pathogenesis. In: J. Gen. Virol. 87 (2006) S. 2767–2779.
Yanagi, Y. The cellular receptor for measles virus — elusive no more. In: Rev. Med. Virol. 11 (2001) S. 149–156.
Young, D. F.; Didcook, L.; Goodbourn, S.; Randall, R. E. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. In: Virology 269 (2000) S. 383–390.
Weiterführende Literatur
Baize, S.; Leroy, E. M.; Georges-Courbot, M.-C.; Capron, M.; Lansoud-Soukate, J.; Debré, P.; Fisher-Hoch, S. P.; McCormick, J. B.; Georges, A. J. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. In: Nature Medicine 5 (1999) S. 423–426.
Barrette, R. W.; Metwally, S. A.; Rowland, J. M.; Xu, L.; Zaki, S. R.; Nichol, S. T.; Rollin, P. E.; Towner, J. S.; Shieh, W. J.; Batten, B.; Sealy, T. K.; Carrillo, C.; Moran, K. E.; Bracht, A. J.; Mayr, G. A.; Sirios-Cruz, M.; Catbagan, D. P.; Lautner, E. A.; Ksiazek, T. G.; White, W. R.; McIntosh, M. T. Discovery of swine as a host for the Reston ebolavirus. In: Science 325 (2009) S. 204–206.
Becker, S.; Spiess, M.; Klenk, H.-D. The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. In: J. Gen. Virol. 76 (1995) S. 393–399.
Cárdenas, W. B.; Loo, Y. M.; Gale, M. Jr.; Hartman, A. L.; Kimberlin, C. R.; Martínez-Sobrido, L.; Saphire, E. O.; Basler, C. F. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. In: J. Virol. 80 (2006) S. 5168–5178.
Falzarano, D.; Krokhin, O.; Van Domselaar, G.; Wolf, K.; Seebach, J.; Schnittler, H. J.; Feldmann, H. Ebola sGP-the first viral glycoprotein shown to be C-mannosylated. In: Virology 368 (2007) S. 83–90.
Groseth, A.; Feldmann, H.; Strong, J. E. The ecology of Ebola virus. In: Trends Microbiol. 15 (2007) S. 408–416.
Hartman, A. L.; Bird, B. H.; Towner, J. S.; Antoniadou, Z. A.; Zaki, S. R.; Nichol, S. T. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. In: J. Virol. 82 (2008) S. 2699–2704.
Gupta, M.; Mahanty S.; Bray, M.; Ahemd, R.; Rollin, P. E. Passive transfer of antibodies protects immunocompetent and immunodeficient mice against lethal Ebola virus infection without complete inhibition of viral replication. In: J. Virol. 75 (2001) S. 4649–4654.
Hoenen, T.; Volchkov, V.; Kolesnikova, L.; Mittler, E.; Timmins, J.; Ottmann, M.; Reynard, O.; Becker, S.; Weissenhorn, W. VP40 octamers are essential for Ebola virus replication. In: J. Virol. 79 (2005) S. 1898–1905.
Hoenen, T.; Groseth, A.; Falzarano, D.; Feldmann, H. Ebola virus: unravelling pathogenesis to combat a deadly disease. In: Trends Mol. Med. 12 (2006) S. 206–215.
Hoenen, T.; Groseth, A.; Kolesnikova, L.; Theriault, S.; Ebihara, H.; Hartlieb, B.; Bamberg, S.; Feldmann, H.; Ströher, U.; Becker, S. Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. In: J. Virol. 14 (2006) S. 7260–7264.
Kaletsky, R. L.; Simmons, G.; Bates, P. Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. In: J. Virol. 81 (2007) S. 13378–13384.
Kubota, T.; Matsuoka, M.; Chang, T. H.; Bray, M.; Jones, S.; Tashiro, M.; Kato, A.; Ozato, K. Ebolavirus VP35 interacts with the cytoplasmic dynein light chain 8. In: J. Virol. 83 (2009) S. 6952–6956.
Lee, J. E.; Fusco, M. L.; Hessell, A. J.; Oswald, W. B.; Burton, D. R.; Saphire, E. O. Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. In: Nature 454 (2008) S. 177–182.
Leung, D. W.; Ginder, N. D.; Fulton, D. B.; Nix, J.; Basler, C. F.; Honzatko, R. B.; Amarasinghe, G. K. Structure of the Ebola VP35 interferon inhibitory domain. In: Proc. Natl. Acad. Sci. USA 106 (2009) S. 411–416.
Mohamadzadeh, M.; Chen, L.; Schmaljohn, A. L. How Ebola and Marburg viruses battle the immune system. In: Nat. Rev. Immunol. 7 (2007) S. 556–567.
Martini, G. A.; Siegert, R. (Hrsg.) Marburg Virus Disease. Berlin (Springer) 1971.
Reynard, O.; Borowiak, M.; Volchkova, V. A.; Delpeut, S.; Mateo, M.; Volchkov, V. E. Ebola virus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. In: J. Virol. 83 (2009) S. 9596–9601.
Volchkov, V. E.; Volchkova, V. A.; Mühlberger, E.; Kolesnikova, L. V.; Weik, M.; Dolnik, O.; Klenk, H.-D. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. In: Science 291 (2001) S. 1965–1969.
Wahl-Jensen, V. M.; Afanasieva, T. A.; Seebach, J.; Ströher, U.; Feldmann, H.; Schnittler, H. J. Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. In: J. Virol. 79 (2005) S. 10442–10450.
Yang, Z.-Y.; Duckers, H. J.; Sullivan, N. J.; Sanchez, A.; Nabel, E. G.; Nabel, G. J. Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. In: Nature Medicine 6 (2000) S. 886–889.
Zampieri, C. A.; Sullivan, N. J.; Nabel, G. J. Immunopathology of highly virulent pathogens: insights from Ebola virus. In: Nat. Immunol. 8 (2007) S. 1159–1164.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2010 Spektrum Akademischer Verlag Heidelberg
About this chapter
Cite this chapter
Modrow, S., Falke, D., Truyen, U., Schätzl, H. (2010). Viren mit einzelsträngigem, kontinuierlichem RNA-Genom in Negativstrangorientierung. In: Molekulare Virologie. Spektrum Akademischer Verlag. https://doi.org/10.1007/978-3-8274-2241-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-8274-2241-5_15
Publisher Name: Spektrum Akademischer Verlag
Print ISBN: 978-3-8274-1833-3
Online ISBN: 978-3-8274-2241-5
eBook Packages: Life Science and Basic Disciplines (German Language)